Update Venetoclax in CLL
Acalabrutinib
Zanubrutinib
Obinutuzumab
UpToDate
Leukemia & Lymphoma Society
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
ASCO: COVID-19 Medical Resources